Subject	Predicate	Object
6mxrIWxO	a	Resource
		Answer
		Written answer
	answer has question	xRTKwzcQ
	answer has answering person	George William Freeman
	answer text	<p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of Orkambi (lumacaftor in combination with ivacaftor) for the treatment of cystic fibrosis in people who are homozygous for the F508del mutation. NICE’s anticipated publication date for this guidance is July 2016. Further information is available at:</p><br /><p>www.nice.org.uk/guidance/indevelopment/gid-tag530</p>
	answer given date	2015-12-15
	answer has answering body	Department of Health
	written answer has answering body	Department of Health
Department of Health	answering body has written answer	6mxrIWxO
Department of Health	answering body has answer	6mxrIWxO
xRTKwzcQ	question has answer	6mxrIWxO
George William Freeman	answering person has answer	6mxrIWxO